Atlas Trials

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Clinical trial NCT06251453 · UNKNOWN

Trial details

NCT number
NCT06251453
Sponsor
Hamad Medical Corporation
Status
UNKNOWN
Study type
OBSERVATIONAL
Atrial Fibrillation
Start date
2023-10-01
Primary completion
2024-12-01
Enrollment
3280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.